SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Three-Year Real-World LEQEMBI Data Presented at CTAD 2026

New three-year real-world data from the LEQEMBI LEADER study were presented at CTAD 2026, including findings on amyloid clearance.

BIIB

Related stories